sphingotec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies.

sphingotec GmbH was established in 2002 and is located in Hennigsdorf near Berlin, Germany. CEO Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible for the development of the “gold standard” sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™).














  • Administration
    Anja Heindl
    Team Assistent
  • Intellectual Property
    Dr. Andrea Sparwaßer
    Patent and Project Manager
  • Marketing
    Dajana Tandler
    Marketing Manager


  • Operations
    Marco Talke
    Lead of Cooperation and Supply
  • Research & Development
    Dr. Tobias Hartmann
    Head of Laboratory
  • Statistics
    Dr. Oliver Hartmann
    Head of Biostatistics



Our company is continually looking for highly motivated team members. If you are interested in joining our innovative team, please contact us at or submit your application and CV HERE.

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy | Imprint

Select an option to continue

Your selection was saved!

More information


To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy. Imprint